Yana Dekempeneer

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Convolutional Neural Network

Top Venues

Molecular pharmaceutics

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Magdalena Rodak, Yana Dekempeneer, Maria Wojewódzka, Vicky Caveliers, Peter Covens, Brian W Miller, Matthijs B Sevenois, Frank Bruchertseifer, Alfred Morgenstern, Tony Lahoutte, Matthias D'Huyvetter, Marek Pruszynski
Preclinical Evaluation of 225Ac-Labeled Single-Domain Antibody for the Treatment of HER2pos Cancer. Molecular cancer therapeutics 21 (12) (2022)
Yana Dekempeneer, Vicky Caveliers, Maarten Ooms, Dominic Maertens, Mireille Gysemans, Tony Lahoutte, Catarina Xavier, Quentin Lecocq, Ken Maes, Peter Covens, Brian W Miller, Frank Bruchertseifer, Alfred Morgenstern, Thomas Cardinaels, Matthias D'Huyvetter
Therapeutic Efficacy of 213Bi-labeled sdAbs in a Preclinical Model of Ovarian Cancer. Molecular pharmaceutics 17 (9) (2020)
Yana Dekempeneer, Tom Bäck, Emma Aneheim, Holger Jensen, Janik Puttemans, Catarina Xavier, Marleen Keyaerts, Stig Palm, Per Albertsson, Tony Lahoutte, Vicky Caveliers, Sture Lindegren, Matthias D'Huyvetter
Labeling of Anti-HER2 Nanobodies with Astatine-211: Optimization and the Effect of Different Coupling Reagents on Their in Vivo Behavior. Molecular pharmaceutics 16 (8) (2019)